{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:14:52Z","timestamp":1791292492777,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1038\/s41569-021-00608-2","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T12:03:04Z","timestamp":1631707384000},"page":"151-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5092-8825","authenticated-orcid":false,"given":"Roddy","family":"Walsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost A.","family":"Offerhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafik","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie R.","family":"Bezzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"608_CR1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","volume":"108","author":"CE Seidman","year":"2011","unstructured":"Seidman, C. E. & Seidman, J. G. Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ. Res. 108, 743\u2013750 (2011).","journal-title":"Circ. Res."},{"key":"608_CR2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/gim.2016.90","volume":"19","author":"R Walsh","year":"2017","unstructured":"Walsh, R. et al. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet. Med. 19, 192\u2013203 (2017).","journal-title":"Genet. Med."},{"key":"608_CR3","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","volume":"138","author":"CY Ho","year":"2018","unstructured":"Ho, C. Y. et al. Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe). Circulation 138, 1387\u20131398 (2018).","journal-title":"Circulation"},{"key":"608_CR4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.119.037661","volume":"141","author":"F Mazzarotto","year":"2020","unstructured":"Mazzarotto, F. et al. Reevaluating the genetic contribution of monogenic dilated cardiomyopathy. Circulation 141, 387\u2013398 (2020).","journal-title":"Circulation"},{"key":"608_CR5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002475","volume":"12","author":"J Ingles","year":"2019","unstructured":"Ingles, J. et al. Evaluating the clinical validity of hypertrophic cardiomyopathy genes. Circ. Genom. Precis. Med. 12, e002460 (2019).","journal-title":"Circ. Genom. Precis. Med."},{"key":"608_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.053033","author":"E Jordan","year":"2021","unstructured":"Jordan, E. et al. An evidence-based assessment of genes in dilated cardiomyopathy. Circulation https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.053033 (2021).","journal-title":"Circulation"},{"key":"608_CR7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003273","volume":"14","author":"CA James","year":"2021","unstructured":"James, C. A. et al. International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework. Circ. Genom. Precis. Med. 14, e003273 (2021).","journal-title":"Circ. Genom. Precis. Med."},{"key":"608_CR8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41588-020-00762-2","volume":"53","author":"R Tadros","year":"2021","unstructured":"Tadros, R. et al. Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect. Nat. Genet. 53, 128\u2013134 (2021).","journal-title":"Nat. Genet."},{"key":"608_CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","volume":"53","author":"AR Harper","year":"2021","unstructured":"Harper, A. R. et al. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nat. Genet. 53, 135\u2013142 (2021).","journal-title":"Nat. Genet."},{"key":"608_CR10","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15823-7","volume":"11","author":"JP Pirruccello","year":"2020","unstructured":"Pirruccello, J. P. et al. Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy. Nat. Commun. 11, 2254 (2020).","journal-title":"Nat. Commun."},{"key":"608_CR11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/bi901086v","volume":"49","author":"R Ziane","year":"2010","unstructured":"Ziane, R. et al. Cell membrane expression of cardiac sodium channel Na(v)1.5 is modulated by alpha-actinin-2 interaction. Biochemistry 49, 166\u2013178 (2010).","journal-title":"Biochemistry"},{"key":"608_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.RES.0000253095.44186.72","volume":"100","author":"L Lu","year":"2007","unstructured":"Lu, L. et al. Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. Circ. Res. 100, 112\u2013120 (2007).","journal-title":"Circ. Res."},{"key":"608_CR13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jacc.2009.11.016","volume":"55","author":"C Chiu","year":"2010","unstructured":"Chiu, C. et al. Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 55, 1127\u20131135 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"608_CR14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCGENETICS.113.000486","volume":"7","author":"F Girolami","year":"2014","unstructured":"Girolami, F. et al. Novel \u03b1-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study. Circ. Cardiovasc. Genet. 7, 741\u2013750 (2014).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"608_CR15","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-014-0099-0","volume":"15","author":"RD Bagnall","year":"2014","unstructured":"Bagnall, R. D., Molloy, L. K., Kalman, J. M. & Semsarian, C. Exome sequencing identifies a mutation in the ACTN2 gene in a family with idiopathic ventricular fibrillation, left ventricular noncompaction, and sudden death. BMC Med. Genet. 15, 99 (2014).","journal-title":"BMC Med. Genet."},{"key":"608_CR16","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911115","volume":"11","author":"M Prondzynski","year":"2019","unstructured":"Prondzynski, M. et al. Disease modeling of a mutation in \u03b1-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy. EMBO Mol. Med. 11, e11115 (2019).","journal-title":"EMBO Mol. Med."},{"key":"608_CR17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41436-020-01049-x","volume":"23","author":"F Mazzarotto","year":"2021","unstructured":"Mazzarotto, F. et al. Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies. Genet. Med. 23, 856\u2013864 (2021).","journal-title":"Genet. Med."},{"key":"608_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41436-020-00970-5","volume":"23","author":"ES Singer","year":"2021","unstructured":"Singer, E. S. et al. Characterization of clinically relevant copy-number variants from exomes of patients with inherited heart disease and unexplained sudden cardiac death. Genet. Med. 23, 86\u201393 (2021).","journal-title":"Genet. Med."},{"key":"608_CR19","doi-asserted-by":"publisher","DOI":"10.1101\/2020.11.19.389064","author":"ME Lindholm","year":"2020","unstructured":"Lindholm, M. E. et al. Mono- and bi-allelic protein truncating variants in alpha-actinin 2 cause cardiomyopathy through distinct mechanisms. bioRxiv https:\/\/doi.org\/10.1101\/2020.11.19.389064 (2020).","journal-title":"bioRxiv"},{"key":"608_CR20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14843-7","volume":"11","author":"M Arvanitis","year":"2020","unstructured":"Arvanitis, M. et al. Genome-wide association and multi-omic analyses reveal ACTN2 as a gene linked to heart failure. Nat. Commun. 11, 1122 (2020).","journal-title":"Nat. Commun."},{"key":"608_CR21","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jacc.2015.10.093","volume":"67","author":"R Almomani","year":"2016","unstructured":"Almomani, R. et al. Biallelic truncating mutations in ALPK3 cause severe pediatric cardiomyopathy. J. Am. Coll. Cardiol. 67, 515\u2013525 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"608_CR22","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1093\/eurheartj\/ehw160","volume":"37","author":"DG Phelan","year":"2016","unstructured":"Phelan, D. G. et al. ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathy. Eur. Heart J. 37, 2586\u20132590 (2016).","journal-title":"Eur. Heart J."},{"key":"608_CR23","doi-asserted-by":"crossref","first-page":"a001859","DOI":"10.1101\/mcs.a001859","volume":"3","author":"AO \u00c7a\u011flayan","year":"2017","unstructured":"\u00c7a\u011flayan, A. O. et al. ALPK3 gene mutation in a patient with congenital cardiomyopathy and dysmorphic features. Cold Spring Harb. Mol. Case Stud. 3, a001859 (2017).","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"608_CR24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/s10038-018-0492-1","volume":"63","author":"H Jaouadi","year":"2018","unstructured":"Jaouadi, H. et al. Novel ALPK3 mutation in a Tunisian patient with pediatric cardiomyopathy and facio-thoraco-skeletal features. J. Hum. Genet. 63, 1077\u20131082 (2018).","journal-title":"J. Hum. Genet."},{"key":"608_CR25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/ajmg.a.61176","volume":"179","author":"K Al Senaidi","year":"2019","unstructured":"Al Senaidi, K. et al. Phenotypic spectrum of ALPK3-related cardiomyopathy. Am. J. Med. Genet. A 179, 1235\u20131240 (2019).","journal-title":"Am. J. Med. Genet. A"},{"key":"608_CR26","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/genes11101201","volume":"11","author":"J Jorholt","year":"2020","unstructured":"Jorholt, J. et al. Two new cases of hypertrophic cardiomyopathy and skeletal muscle features associated with ALPK3 homozygous and compound heterozygous variants. Genes 11, 1201 (2020).","journal-title":"Genes"},{"key":"608_CR27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ahj.2020.03.023","volume":"225","author":"JC Herkert","year":"2020","unstructured":"Herkert, J. C. et al. Expanding the clinical and genetic spectrum of ALPK3 variants: phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants. Am. Heart J. 225, 108\u2013119 (2020).","journal-title":"Am. Heart J."},{"key":"608_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab424","author":"LR Lopes","year":"2021","unstructured":"Lopes, L. R. et al. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy. Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehab424 (2021).","journal-title":"Eur. Heart J."},{"key":"608_CR29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003127","volume":"13","author":"C Cheawsamoot","year":"2020","unstructured":"Cheawsamoot, C. et al. A pathogenic variant in ALPK3 is associated with an autosomal dominant adult-onset hypertrophic cardiomyopathy. Circ. Genom. Precis. Med. 13, e003127 (2020).","journal-title":"Circ. Genom. Precis. Med."},{"key":"608_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0300985811402841","volume":"49","author":"I Van Sligtenhorst","year":"2012","unstructured":"Van Sligtenhorst, I. et al. Cardiomyopathy in \u03b1-kinase 3 (ALPK3)-deficient mice. Vet. Pathol. 49, 131\u2013141 (2012).","journal-title":"Vet. Pathol."},{"key":"608_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2015.04.077","volume":"566","author":"E Vafiadaki","year":"2015","unstructured":"Vafiadaki, E., Arvanitis, D. A. & Sanoudou, D. Muscle LIM protein: master regulator of cardiac and skeletal muscle functions. Gene 566, 1\u20137 (2015).","journal-title":"Gene"},{"key":"608_CR32","first-page":"3461","volume":"38","author":"R Walsh","year":"2017","unstructured":"Walsh, R. et al. Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes. Eur. Heart J. 38, 3461\u20133468 (2017).","journal-title":"Eur. Heart J."},{"key":"608_CR33","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1093\/hmg\/ddn160","volume":"17","author":"C Geier","year":"2008","unstructured":"Geier, C. et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum. Mol. Genet. 17, 2753\u20132765 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"608_CR34","doi-asserted-by":"crossref","first-page":"104079","DOI":"10.1016\/j.ejmg.2020.104079","volume":"63","author":"J Salazar-Mendiguch\u00eda","year":"2020","unstructured":"Salazar-Mendiguch\u00eda, J. et al. The p.(Cys150Tyr) variant in CSRP3 is associated with late-onset hypertrophic cardiomyopathy in heterozygous individuals. Eur. J. Med. Genet. 63, 104079 (2020).","journal-title":"Eur. J. Med. Genet."},{"key":"608_CR35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.gene.2018.07.036","volume":"676","author":"A Janin","year":"2018","unstructured":"Janin, A., Bessi\u00e8re, F., Chauveau, S., Chevalier, P. & Millat, G. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy. Gene 676, 110\u2013116 (2018).","journal-title":"Gene"},{"key":"608_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.20452\/pamw.15169","volume":"130","author":"M Lipari","year":"2020","unstructured":"Lipari, M. et al. Identification of a variant hotspot in MYBPC3 and of a novel CSRP3 autosomal recessive alteration in a cohort of Polish patients with hypertrophic cardiomyopathy. Pol. Arch. Intern. Med. 130, 89\u201399 (2020).","journal-title":"Pol. Arch. Intern. Med."},{"key":"608_CR37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0092-8674(00)81878-4","volume":"88","author":"S Arber","year":"1997","unstructured":"Arber, S. et al. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88, 393\u2013403 (1997).","journal-title":"Cell"},{"key":"608_CR38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCRESAHA.109.206243","volume":"106","author":"R Kn\u00f6ll","year":"2010","unstructured":"Kn\u00f6ll, R. et al. A common MLP (muscle LIM protein) variant is associated with cardiomyopathy. Circ. Res. 106, 695\u2013704 (2010).","journal-title":"Circ. Res."},{"key":"608_CR39","doi-asserted-by":"crossref","first-page":"29873","DOI":"10.1074\/jbc.M109.059303","volume":"284","author":"K Taniguchi","year":"2009","unstructured":"Taniguchi, K. et al. Mammalian formin Fhod3 regulates actin assembly and sarcomere organization in striated muscles. J. Biol. Chem. 284, 29873\u201329881 (2009).","journal-title":"J. Biol. Chem."},{"key":"608_CR40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCGENETICS.112.965277","volume":"6","author":"EC Wooten","year":"2013","unstructured":"Wooten, E. C. et al. Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy. Circ. Cardiovasc. Genet. 6, 10\u201318 (2013).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"608_CR41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172995","volume":"12","author":"U Esslinger","year":"2017","unstructured":"Esslinger, U. et al. Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy. PLoS One 12, e0172995 (2017).","journal-title":"PLoS One"},{"key":"608_CR42","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.jacc.2018.10.001","volume":"72","author":"JP Ochoa","year":"2018","unstructured":"Ochoa, J. P. et al. Formin homology 2 domain containing 3 (FHOD3) is a genetic basis for hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 72, 2457\u20132467 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"608_CR43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cge.13759","volume":"98","author":"JP Ochoa","year":"2020","unstructured":"Ochoa, J. P. et al. Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathy. Clin. Genet. 98, 86\u201390 (2020).","journal-title":"Clin. Genet."},{"key":"608_CR44","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jacc.2018.12.060","volume":"73","author":"C Semsarian","year":"2019","unstructured":"Semsarian, C., Ingles, J. & Bagnall, R. D. Revisiting genome sequencing data in light of novel disease gene associations. J. Am. Coll. Cardiol. 73, 1365\u20131366 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"608_CR45","doi-asserted-by":"publisher","DOI":"10.1101\/2020.10.12.20211474","author":"R Lesurf","year":"2020","unstructured":"Lesurf, R. et al. Whole genome sequencing delineates regulatory and novel genic variants in childhood cardiomyopathy. medRxiv https:\/\/doi.org\/10.1101\/2020.10.12.20211474 (2020).","journal-title":"medRxiv"},{"key":"608_CR46","volume":"10","author":"G Wu","year":"2021","unstructured":"Wu, G. et al. Variant spectrum of formin homology 2 domain-containing 3 gene in Chinese patients with hypertrophic cardiomyopathy. J. Am. Heart Assoc. 10, e018236 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"608_CR47","doi-asserted-by":"crossref","first-page":"E4386","DOI":"10.1073\/pnas.1716498115","volume":"115","author":"S Matsuyama","year":"2018","unstructured":"Matsuyama, S. et al. Interaction between cardiac myosin-binding protein C and formin Fhod3. Proc. Natl Acad. Sci. USA 115, E4386\u2013E4395 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"608_CR48","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1253\/circj.CJ-13-0255","volume":"77","author":"T Arimura","year":"2013","unstructured":"Arimura, T. et al. Dilated cardiomyopathy-associated FHOD3 variant impairs the ability to induce activation of transcription factor serum response factor. Circ. J. 77, 2990\u20132996 (2013).","journal-title":"Circ. J."},{"key":"608_CR49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1242\/bio.20121370","volume":"1","author":"M Kan-O","year":"2012","unstructured":"Kan-O, M. et al. Mammalian formin Fhod3 plays an essential role in cardiogenesis by organizing myofibrillogenesis. Biol. Open 1, 889\u2013896 (2012).","journal-title":"Biol. Open"},{"key":"608_CR50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1086\/431959","volume":"77","author":"M Vorgerd","year":"2005","unstructured":"Vorgerd, M. et al. A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am. J. Hum. Genet. 77, 297\u2013304 (2005).","journal-title":"Am. J. Hum. Genet."},{"key":"608_CR51","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6326","volume":"5","author":"R Vald\u00e9s-Mas","year":"2014","unstructured":"Vald\u00e9s-Mas, R. et al. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy. Nat. Commun. 5, 5326 (2014).","journal-title":"Nat. Commun."},{"key":"608_CR52","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/humu.24004","volume":"41","author":"JAJ Verdonschot","year":"2020","unstructured":"Verdonschot, J. A. J. et al. A mutation update for the FLNC gene in myopathies and cardiomyopathies. Hum. Mutat. 41, 1091\u20131111 (2020).","journal-title":"Hum. Mutat."},{"key":"608_CR53","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2017.26","volume":"19","author":"N Whiffin","year":"2017","unstructured":"Whiffin, N. et al. Using high-resolution variant frequencies to empower clinical genome interpretation. Genet. Med. 19, 1151\u20131158 (2017).","journal-title":"Genet. Med."},{"key":"608_CR54","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001584","volume":"10","author":"J G\u00f3mez","year":"2017","unstructured":"G\u00f3mez, J. et al. Screening of the Filamin C gene in a large cohort of hypertrophic cardiomyopathy patients. Circ. Cardiovasc. Genet. 10, e001584 (2017).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"608_CR55","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/mgg3.488","volume":"6","author":"H Cui","year":"2018","unstructured":"Cui, H. et al. Mutation profile of FLNC gene and its prognostic relevance in patients with hypertrophic cardiomyopathy. Mol. Genet. Genomic Med. 6, 1104\u20131113 (2018).","journal-title":"Mol. Genet. Genomic Med."},{"key":"608_CR56","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/s41436-018-0375-z","volume":"21","author":"KL Thomson","year":"2019","unstructured":"Thomson, K. L. et al. Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield. Genet. Med. 21, 1576\u20131584 (2019).","journal-title":"Genet. Med."},{"key":"608_CR57","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","volume":"68","author":"MF Ortiz-Genga","year":"2016","unstructured":"Ortiz-Genga, M. F. et al. Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies. J. Am. Coll. Cardiol. 68, 2440\u20132451 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"608_CR58","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","volume":"4","author":"RL Begay","year":"2018","unstructured":"Begay, R. L. et al. Filamin C truncation mutations are associated with arrhythmogenic dilated cardiomyopathy and changes in the cell-cell adhesion structures. JACC Clin. Electrophysiol. 4, 504\u2013514 (2018).","journal-title":"JACC Clin. Electrophysiol."},{"key":"608_CR59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/cge.13594","volume":"96","author":"F Ader","year":"2019","unstructured":"Ader, F. et al. FLNC pathogenic variants in patients with cardiomyopathies: prevalence and genotype-phenotype correlations. Clin. Genet. 96, 317\u2013329 (2019).","journal-title":"Clin. Genet."},{"key":"608_CR60","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/cge.13043","volume":"92","author":"A Janin","year":"2017","unstructured":"Janin, A. et al. Truncating mutations on myofibrillar myopathies causing genes as prevalent molecular explanations on patients with dilated cardiomyopathy. Clin. Genet. 92, 616\u2013623 (2017).","journal-title":"Clin. Genet."},{"key":"608_CR61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2019.09.048","volume":"307","author":"CL Hall","year":"2020","unstructured":"Hall, C. L. et al. Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype. Int. J. Cardiol. 307, 101\u2013108 (2020).","journal-title":"Int. J. Cardiol."},{"key":"608_CR62","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCULATIONAHA.120.052395","volume":"143","author":"R Goli","year":"2021","unstructured":"Goli, R. et al. Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation 143, 1852\u20131862 (2021).","journal-title":"Circulation"},{"key":"608_CR63","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1128\/MCB.00243-06","volume":"26","author":"I Dalkilic","year":"2006","unstructured":"Dalkilic, I., Schienda, J., Thompson, T. G. & Kunkel, L. M. Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure. Mol. Cell. Biol. 26, 6522\u20136534 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"608_CR64","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","volume":"14","author":"PA van der Zwaag","year":"2012","unstructured":"van der Zwaag, P. A. et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur. J. Heart Fail. 14, 1199\u20131207 (2012).","journal-title":"Eur. J. Heart Fail."},{"key":"608_CR65","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1081578","volume":"299","author":"JP Schmitt","year":"2003","unstructured":"Schmitt, J. P. et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299, 1410\u20131413 (2003).","journal-title":"Science"},{"key":"608_CR66","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1172\/JCI17892","volume":"111","author":"K Haghighi","year":"2003","unstructured":"Haghighi, K. et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J. Clin. Invest. 111, 869\u2013876 (2003).","journal-title":"J. Clin. Invest."},{"key":"608_CR67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2018.12.075","volume":"279","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. A PLN nonsense variant causes severe dilated cardiomyopathy in a novel autosomal recessive inheritance mode. Int. J. Cardiol. 279, 122\u2013125 (2019).","journal-title":"Int. J. Cardiol."},{"key":"608_CR68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181465","volume":"12","author":"I Mademont-Soler","year":"2017","unstructured":"Mademont-Soler, I. et al. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy. PLoS One 12, e0181465 (2017).","journal-title":"PLoS One"},{"key":"608_CR69","volume":"13","author":"SUM Vanninen","year":"2018","unstructured":"Vanninen, S. U. M. et al. Heterozygous junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure. PLoS One 13, e0203422 (2018).","journal-title":"PLoS One"},{"key":"608_CR70","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/cge.12825","volume":"90","author":"M Sabater-Molina","year":"2016","unstructured":"Sabater-Molina, M. et al. Mutation in JPH2 cause dilated cardiomyopathy. Clin. Genet. 90, 468\u2013469 (2016).","journal-title":"Clin. Genet."},{"key":"608_CR71","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2018.08.2171","volume":"72","author":"C Vasilescu","year":"2018","unstructured":"Vasilescu, C. et al. Genetic basis of severe childhood-onset cardiomyopathies. J. Am. Coll. Cardiol. 72, 2324\u20132338 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"608_CR72","volume":"9","author":"EG Jones","year":"2019","unstructured":"Jones, E. G. et al. Analysis of enriched rare variants in JPH2-encoded junctophilin-2 among greater middle eastern individuals reveals a novel homozygous variant associated with neonatal dilated cardiomyopathy. Sci. Rep. 9, 9038 (2019).","journal-title":"Sci. Rep."},{"key":"608_CR73","first-page":"11","volume":"6","author":"H Takeshima","year":"2000","unstructured":"Takeshima, H., Komazaki, S., Nishi, M., Iino, M. & Kangawa, K. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell 6, 11\u201322 (2000).","journal-title":"Mol. Cell"},{"key":"608_CR74","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2020-316913","volume":"106","author":"J Salazar-Mendiguch\u00eda","year":"2020","unstructured":"Salazar-Mendiguch\u00eda, J. et al. Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy. Heart 106, 1342\u20131348 (2020).","journal-title":"Heart"},{"key":"608_CR75","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.3390\/ijms15069302","volume":"15","author":"M Su","year":"2014","unstructured":"Su, M. et al. Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy. Int. J. Mol. Sci. 15, 9302\u20139313 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"608_CR76","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.emboj.7601952","volume":"27","author":"CC Witt","year":"2008","unstructured":"Witt, C. C. et al. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J. 27, 350\u2013360 (2008).","journal-title":"EMBO J."},{"key":"608_CR77","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/01.RES.0000259559.48597.32","volume":"100","author":"MS Willis","year":"2007","unstructured":"Willis, M. S. et al. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo. Circ. Res. 100, 456\u2013459 (2007).","journal-title":"Circ. Res."},{"key":"608_CR78","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/hmg\/ddz032","volume":"28","author":"C Hedberg-Oldfors","year":"2019","unstructured":"Hedberg-Oldfors, C. et al. Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24. Hum. Mol. Genet. 28, 1919\u20131929 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"608_CR79","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/ng.3701","volume":"48","author":"Z Lin","year":"2016","unstructured":"Lin, Z. et al. Stabilizing mutations of KLHL24 ubiquitin ligase cause loss of keratin 14 and human skin fragility. Nat. Genet. 48, 1508\u20131516 (2016).","journal-title":"Nat. Genet."},{"key":"608_CR80","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jid.2018.07.022","volume":"139","author":"A Schwieger-Briel","year":"2019","unstructured":"Schwieger-Briel, A. et al. Epidermolysis bullosa simplex with KLHL24 mutations is associated with dilated cardiomyopathy. J. Invest. Dermatol. 139, 244\u2013249 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"608_CR81","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140615","author":"MCSC Vermeer","year":"2021","unstructured":"Vermeer, M. C. S. C. et al. Gain-of-function mutation in ubiquitin-ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI140615 (2021).","journal-title":"J. Clin. Invest."},{"key":"608_CR82","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.jacc.2018.08.2181","volume":"72","author":"F Dom\u00ednguez","year":"2018","unstructured":"Dom\u00ednguez, F. et al. Dilated cardiomyopathy due to BLC2-associated athanogene 3 (BAG3) mutations. J. Am. Coll. Cardiol. 72, 2471\u20132481 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"608_CR83","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/gim.2014.205","volume":"17","author":"AA Alfares","year":"2015","unstructured":"Alfares, A. A. et al. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet. Med. 17, 880\u2013888 (2015).","journal-title":"Genet. Med."},{"key":"608_CR84","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/gim.2017.218","volume":"20","author":"MA Kelly","year":"2018","unstructured":"Kelly, M. A. et al. Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s inherited cardiomyopathy expert panel. Genet. Med. 20, 351\u2013359 (2018).","journal-title":"Genet. Med."},{"key":"608_CR85","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-019-0616-z","volume":"11","author":"R Walsh","year":"2019","unstructured":"Walsh, R. et al. Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy. Genome Med. 11, 5 (2019).","journal-title":"Genome Med."},{"key":"608_CR86","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2013.03.062","volume":"62","author":"I Olivotto","year":"2013","unstructured":"Olivotto, I. et al. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 62, 449\u2013457 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"608_CR87","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41588-018-0192-y","volume":"50","author":"SE Castel","year":"2018","unstructured":"Castel, S. E. et al. Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk. Nat. Genet. 50, 1327\u20131334 (2018).","journal-title":"Nat. Genet."},{"key":"608_CR88","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","volume":"74","author":"S Neubauer","year":"2019","unstructured":"Neubauer, S. et al. Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry. J. Am. Coll. Cardiol. 74, 2333\u20132345 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"608_CR89","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35788","volume":"7","author":"LE Montefiori","year":"2018","unstructured":"Montefiori, L. E. et al. A promoter interaction map for cardiovascular disease genetics. eLife 7, e35788 (2018).","journal-title":"eLife"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00608-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00608-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00608-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T20:57:28Z","timestamp":1699477048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41569-021-00608-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1038\/s41569-021-00608-2","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"2 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}